Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
“Odisha will be a leading destination for pharmaceutical and medical‑device inv...
The expansion is targeted at individuals for whom topical corticosteroids are no...
The investment values Swixx at more than €1.5bn ($1.76bn). Swixx operates as a c...
Adarsh Padmanabha highlights how cold-chain-ready, in-city warehousing is resha...
Unified summit to bring biologics and 3D cell culture communities on a single p...
Mahesh Patil explains why the pharmaceutical industry must realign ORS formulat...
Sobi will purchase for Arthrosi Skr9.1bn ($950m) in cash. Additional payments of...
Rett syndrome is a rare neurodevelopmental disorder that progresses through four...
Lancet publication and ovarian cancer trial discussed at Kolkata meeting The po...
DCGI-approved extended-release formulation introduced for once-daily dosing in ...
State government to launch pharma and medical devices policy and announce indu...
The products are marketed as Diavorin and Vobexoryn through Pharmamedic B.V. T...
The multi-programme partnership leverages Zealand Pharma’s experience in obesity...
The approval marks the first new treatment for the adult population with PPF in ...
This next-generation central nervous system (CNS)-penetrant will be developed by...
The approvals mark the fourth and fifth clearances for the company in the countr...
